Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.069 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |